Acucela Inc is categorized under Commercial Biotechnical Research in Seattle, WA and active since 2002.
Acucela Inc was established in 2002, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 4461100 by the NAICS.
If you are seeking more information, feel free to contact Ryo Kubota, Chief Executive Officer at the company’s single location by writing to 1301 2nd Avenue # 1900, Seattle, Washington WA 98101 or by phoning (206) 805-8300. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Acucela Inc |
| Contact Person: | Ryo Kubota, Chief Executive Officer |
| Address: | 1301 2nd Avenue # 1900, Seattle, Washington 98101 |
| Phone Number: | (206) 805-8300 |
| Website Address: | acucela.com |
| Annual Revenue (USD): | $2.500.000 to $4.999.999 |
| Founded: | 2002 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Biotechnical Research |
| SIC Code: | 8731 |
| NAICS Code: | 4461100 |
| Share This Business: |
Acucela Inc was started in 2002 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 4461100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.
Feel free to contact Ryo Kubota, Chief Executive Officer for inquiries that concern Acucela Inc by calling the company number (206) 805-8300, as your correspondence is most welcome. Additionally, the physical location of the single location of Acucela Inc can be found at the coordinates 47.607295,-122.337188 as well as the street address 1301 2nd Avenue # 1900 in Seattle, Washington 98101.
For its online presence, you may visit Acucela Inc’s website at acucela.com and engage with its social media outlets through on Twitter and on Facebook.